Established in 2015, the Applied Therapeutics, Research, and Instruction at the University of Maryland (ATRIUM) Cardiology Collaborative is focused on the pharmaceutical care of patients with cardiovascular diseases.
Members of the ATRIUM Cardiology Collaborative strive to be recognized as the foremost experts in cardiovascular pharmacotherapy through advanced-level clinical practice and training, innovative instructional methodology, and significant contributions to science. Through this recognition, they hope to elevate practice, education, and research; grow the influence of the University of Maryland School of Pharmacy; and advance the care provided to patients with cardiovascular diseases.
This two-minute video provides an overview of the ATRIUM Cardiology Collaborative at the University of Maryland School of Pharmacy, which focuses on the pharmaceutical care of patients with cardiovascular diseases.
January 17, 2019AC in ESRD (Part 1): First, Do No Harm – No Anticoagulation in Patients with End Stage Renal Disease and Atrial Fibrillation
December 27, 2018Post-TAVR Antithrombotic Therapy: What To Do When No One Knows What To Do
December 18, 2018Transitions Squared: Transitioning Sacubitril/Valsartan at Transitions of Care